Verve Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Verve Therapeutics, Inc. has filed 344 SEC EDGAR filings since 22 Jan 2021

SEC filing history

Showing 51-75 of 344 matching filings.

Per page
25
Current page
3
EFFECT File 333-267578

EFFECT filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92605

SCHEDULE 13G filing

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40489

ARS

Filing date
25 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40489

DEFA14A

Filing date
25 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40489

DEF 14A

Filing date
25 Apr 2025
Reporting date
05 Jun 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-92605

SCHEDULE 13G/A filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-267578

POS AM

Filing date
27 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285309

S-8

Filing date
27 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-267578

POSASR

Filing date
27 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92605

SCHEDULE 13G filing

Filing date
05 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92605

SCHEDULE 13G/A filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92605

SCHEDULE 13G/A filing

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .